Revolution Medicines, Inc. Other Non-Current Liabilities increased by 469.5% to $6.88M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 66.2%, from $4.14M to $6.88M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 13.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Significant changes may reflect shifts in lease accounting, changes in employee benefit plans, or the emergence of long-term legal risks.
A catch-all category for long-term obligations that do not fall into major classifications like debt or deferred taxes....
Varies significantly by industry; companies with large physical retail footprints often show higher values here due to long-term leases.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $608.00K | $932.00K | $634.00K | $1.63M | $219.00K | $471.00K | $301.00K | $1.69M | $252.00K | $982.00K | $1.46M | $3.04M | $656.00K | $1.64M | $670.00K | $4.14M | $7.20M | $2.48M | $1.21M | $6.88M |
| QoQ Change | — | +53.3% | -32.0% | +157.7% | -86.6% | +115.1% | -36.1% | +462.8% | -85.1% | +289.7% | +48.5% | +108.5% | -78.4% | +150.6% | -59.2% | +517.6% | +74.1% | -65.6% | -51.3% | +469.5% |
| YoY Change | — | — | — | — | -64.0% | -49.5% | -52.5% | +3.7% | +15.1% | +108.5% | +384.4% | +79.5% | +160.3% | +67.4% | -54.0% | +36.1% | +998.2% | +50.8% | +80.3% | +66.2% |